Cronos Group stock: growth
CRONCronos Group reported $149.15M in revenue for fiscal 2025, up 26.8% on the prior year, up 29.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 26.1% | 45.9% | no data |
| Revenue per share | 23.8% | 15.9% | no data |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $0 | −$31.16K | $0 |
| 2014 | −$665K | −$4.15M | −$2.39M |
| 2015 | $3.41M | $278.28K | −$2.08M |
| 2016 | $412.32K | −$1.2M | −$5.95M |
| 2017 | $4.14M | $2.53M | −$38.37M |
| 2018 | $12.12M | −$21.64M | −$91.41M |
| 2019 | $17.84M | $1.19B | −$126.9M |
| 2020 | $46.72M | −$73.14M | −$180.26M |
| 2021 | $64.56M | −$396.11M | −$165.88M |
| 2022 | $86.75M | −$168.73M | −$93.98M |
| 2023 | $87.24M | −$73.96M | −$46.26M |
| 2024 | $117.62M | $41.08M | $5.69M |
| 2025 | $149.15M | −$9.61M | $151.61K |
Revenue by segment
How Cronos Group Inc. makes its money and how that has shifted. Names are as the company reports them.
- Cannabis Flower73%
- Cannabis Extracts25%
- Other2%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| Cannabis Flower | $62.07M | $87.91M | $108.48M | 72.7% |
| Cannabis Extracts | $24.57M | $29.17M | $37.7M | 25.3% |
| Other | $0 | $0 | $2.98M | 2% |
| Total revenue | $87.24M | $117.62M | $149.15M | 100% |
Revenue by region
Where Cronos Group Inc. generates its revenue.
- Canada61%
- Israel28%
- Other11%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| Canada | $64.7M | $82.44M | $90.33M | 60.6% |
| Israel | $21.13M | $28.37M | $41.8M | 28% |
| Other | $1.41M | $6.81M | $17.03M | 11.4% |
| Total revenue | $87.24M | $117.62M | $149.15M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
